Accessibility Menu
Precigen logo

Precigen

(NASDAQ) PGEN

Current Price$5.35
Market Cap$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-78%
5 Year-12%
1 Year+179%
1 Month+37%

Precigen Financials at a Glance

Market Cap

$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$31.60M

Net Income (TTM)

-$204.42M

EPS (TTM)

-$1.24

P/E Ratio

-4.30

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Price

$5.35

Volume

3,455,433.559

Open

$5.50

Previous Close

$5.32

Daily Range

$5.17 - $5.50

52-Week Range

$1.47 - $6.04

Estimated Earnings Date

Aug 11, 2026

PGEN: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precigen

Industry

Biotechnology

Employees

160

CEO

Helen Sabzevari, PhD

Headquarters

Germantown, MD 20876, US

PGEN Financials

Key Financial Metrics (TTM)

Gross Margin

75.63%

Operating Margin

-297.21%

Net Income Margin

-646.99%

Return on Equity

-1768.51%

Return on Capital

-89.43%

Return on Assets

-147.46%

Earnings Yield

-23.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

356.51M

Volume

3.46M

Avg. Volume

4.46M

Financials (TTM)

Gross Profit

$23.90M

Operating Income

-$93.91M

EBITDA

-$195.19M

Operating Cash Flow

-$115.33M

Capital Expenditure

-$2.24M

Free Cash Flow

-$117.57M

Cash & ST Invst.

$56.25M

Total Debt

$98.25M

Precigen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$23.25M

+1633.9%

Gross Profit

$20.38M

+26221.8%

Gross Margin

87.63%

N/A

Market Cap

$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$13.26M

N/A

Employees

143

N/A

Net Income

-$7.93M

+85.4%

EBITDA

-$3.92M

+92.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$56.25M

-29.9%

Total Debt

$98.25M

+1713.7%

Accounts Receivable

$26.71M

+2409.9%

Inventory

$14.73M

N/A

Long Term Debt

$97.18M

+2064.9%

Short Term Debt

$1.07M

+15.1%

Return on Assets

-1.47%

N/A

Return on Invested Capital

-79.90%

N/A

Free Cash Flow

-$44.09M

-160.1%

Operating Cash Flow

-$43.83M

-168.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMLXAmylyx Pharmaceuticals, Inc.
$17.77-3.32%
NKTRNektar Therapeutics
$70.36-3.51%
IMTXImmatics N.V.
$9.68-2.81%
TRMLTourmaline Bio, Inc.
$47.98+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$18.78+0.01%
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%
INTCIntel
$109.84-0.02%

Questions About PGEN

What is the current price of Precigen?

Precigen is trading at $5.32 per share.

What is the 52-week range for Precigen?

Over the past 52 weeks, Precigen has traded between $1.47 and $6.04.

How much debt does Precigen have?

As of the most recent reporting period, Precigen reported total debt of $98.25M.

How much cash does Precigen have on hand?

Precigen reported $7.48M in cash and cash equivalents in its most recent financial results.

What is Precigen’s dividend yield?

Precigen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.